DOES TESTING FOR CIRCULATING AUTOANTIBODIES AGAINST DISEASE-RELEVANT CITRULLINATED ANTIGENS ADD VALUE TO THE CCP2 ASSAY IN DIAGNOSING RA AMONG EARLY UNDIFFERENTIATED ARTHRITIS PATIENTS?

Documenti analoghi

• DOES TESTING FOR CIRCULATING AUTOANTIBODIES AGAINST DISEASE-RELEVANT CITRULLINATED ANTIGENS ADD VALUE TO THE CCP2 ASSAY IN DIAGNOSING RA AMONG EARLY UNDIFFERENTIATED ARTHRITIS PATIENTS?
  di: Pratt, A, et al.
  Pubblicazione: (2011)
• Serotyping for an extended anti-citrullinated peptide autoantibody panel does not add value to CCP2 testing for diagnosing RA in an early undifferentiated arthritis cohort.
  di: Pratt, A, et al.
  Pubblicazione: (2011)
• Serotyping for an extended anti-citrullinated peptide autoantibody panel does not add value to CCP2 testing for diagnosing RA in an early undifferentiated arthritis cohort
  di: Pratt, A, et al.
  Pubblicazione: (2011)
• A comparison of anti-cyclic citrullinated peptides (CCP3 and CCP3.1) autoantibody tests in rheumatoid arthritis
  di: Heather A. Nelson, et al.
  Pubblicazione: (2024-08-01)
• Periodontitis in RA-the citrullinated enolase connection.
  di: Lundberg, K, et al.
  Pubblicazione: (2010)